Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Challenging Cases with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
|
Jul 21, 2025 |
How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025
|
Jul 17, 2025 |
How to Treat Early Stage Non-Small Cell Lung Cancer in 2025
|
Jul 10, 2025 |
ASCO 2025 - GU Cancer Highlights: KEYNOTE-564, AMPLITUDE, ARANOTE, NIAGARA
|
Jul 04, 2025 |
FDA Approval of Telisotuzumab (Teliso-V) in c-MET Overexpression - LUMINOSITY trial
|
Jun 27, 2025 |
ASCO 2025 - Breast Cancer Highlights: INAVO120, SERENA-6, VERITAC-2, DESTINY-Breast09, ASCENT-04
|
Jun 20, 2025 |
ASCO 2025 - GI Cancer Highlights: DYNAMIC III, ATOMIC, BREAKWATER, MATTERHORN, DESTINY Gastric04
|
Jun 14, 2025 |
ASCO 2025 Lung Cancer Highlights: CheckMate 816, ToD, NeoADAURA, IMforte, DeLLphi 304
|
Jun 07, 2025 |
Nivolumab plus Ipilimumab in Microsatellite-Instability–High (MSI-H) Metastatic Colorectal Cancer
|
May 26, 2025 |
Managing Toxicities of EGFR Inhibitors: Afatinib, Amivantamab-Lazertinib, Osimertinib
|
May 21, 2025 |
How to treat Small Cell Lung Cancer in 2025
|
May 19, 2025 |
Treatment of Metastatic Non-Small Cell Lung Cancer With Targeted Mutations
|
May 15, 2025 |
How to Treat Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Targeted Mutations
|
May 12, 2025 |
Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)
|
May 08, 2025 |
Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer
|
May 05, 2025 |
Treatment Options for HER2 Positive Biliary Tract Cancers
|
May 01, 2025 |
The HER2 Diagnostic and Treatment Landscape in NSCLC
|
Apr 29, 2025 |
Overview of Biliary Tract Cancer & Importance of Targeted Therapies
|
Apr 24, 2025 |
What does it mean to be HER2 Positive in Lung Cancer
|
Apr 21, 2025 |
European Lung Cancer Conference (ELCC) 2025 Highlights: KEYNOTE-799, LAURA, MARIPOSA, KRYSTAL-7
|
Apr 14, 2025 |
FDA Approval of Cabozantinib - CABINET in pNET and epNET
|
Apr 10, 2025 |
How to Manage & Treat Pancreatic Cancer
|
Apr 07, 2025 |
How to Treat Upper Gastrointestinal Cancers in 2025 - Treatment Algorithm
|
Mar 31, 2025 |
ToxCheck: Managing Side Effects of Pancreatic Cancer Treatment
|
Mar 27, 2025 |
Prostate Cancer Management from Early Stage to Advanced Metastatic Disease - Dr. Alan Bryce
|
Mar 24, 2025 |
How to Treat Renal Cell Carcinoma (RCC) using a Treatment Algorithm with Dr. Katy Beckermann
|
Mar 17, 2025 |
How to Treat Bladder Cancer in 2025 with Dr. Joaquim Bellmunt
|
Mar 10, 2025 |
FDA Approval of Tislelizumab - RATIONALE 305 and 306 in Upper GI Cancers
|
Mar 06, 2025 |
GU ASCO 2025 Highlights - TALAPRO-2, NIAGARA, CheckMate-9ER, TiNivo-2
|
Mar 03, 2025 |
How to Treat Hormone Receptor Positive Cancer - Latest Advancements and Current Standard of Care in 2025
|
Feb 24, 2025 |
FDA Approval of Zolbetuximab SPOTLIGHT / GLOW study - Upper GI Cancer with Claudin 18.2 Mutation
|
Feb 21, 2025 |
How to Treat HER2+ Breast Cancer - Discussion with Dr. Sarah Sammons
|
Feb 17, 2025 |
How to Treat Triple Negative Breast Cancer - Discussion with Dr. Virginia Kaklamani
|
Feb 10, 2025 |
GI ASCO 2025 Highlights - BREAKWATER, CheckMate-8HW, ALASCCA, STARTER-NET
|
Feb 03, 2025 |
FDA Approval of Subcutaneous Nivolumab CheckMate-67T - Subcutaneous Nivo vs. Intravenous (IV) Nivo
|
Jan 31, 2025 |
Intermediate HCC – the evolving role of Immunotherapy with Multimodality approaches
|
Jan 27, 2025 |
Managing Side Effects of Anti-VEGF Bevacizumab & Anti-EGFR Cetuximab and Panitumumab
|
Jan 22, 2025 |
ASH Lymphoma 2024 Highlights - POLARIX Update, inMIND, TRIANGLE, ENRICH with Dr. Pallawi Torka
|
Jan 21, 2025 |
SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney
|
Jan 17, 2025 |
SABCS 2024 Highlights - EUROPA, TAILORx, PADMA, EMBER-3 with Dr. Jame Abraham
|
Jan 15, 2025 |
Intermediate Hepatocellular Carcinoma (HCC) – Treatment Options & Strategies
|
Jan 13, 2025 |
SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA
|
Jan 09, 2025 |
Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski
|
Jan 07, 2025 |
FDA Approval of Zanidatamab - HERIZON-BTC-01 Discussion with Dr. Shubham Pant
|
Jan 02, 2025 |
ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL, Role of CAR-T Cell Therapy
|
Dec 26, 2024 |
CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy
|
Dec 21, 2024 |
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
|
Dec 19, 2024 |
2nd line treatment in advanced HCC and when to switch
|
Dec 13, 2024 |
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
|
Dec 02, 2024 |
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
|
Nov 28, 2024 |
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
|
Nov 25, 2024 |
How to Approach and Treat Pancreatic Cancer
|
Nov 21, 2024 |
Understanding the Impact of Nutrition & Exercise on Cancer Outcomes
|
Nov 18, 2024 |
How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)
|
Nov 14, 2024 |
Palliative Care Management in Cancer
|
Nov 08, 2024 |
How to Approach to Ovarian Cancer from Community Oncology Perspective
|
Oct 31, 2024 |
How to Approach to Endometrial Cancer from Community Oncology Perspective
|
Oct 24, 2024 |
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)
|
Oct 22, 2024 |
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
|
Oct 20, 2024 |
Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATIC
|
Oct 17, 2024 |
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
|
Oct 15, 2024 |
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
|
Oct 13, 2024 |
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2
|
Oct 10, 2024 |
GU Cancer ESMO 2024 Highlights: Key Studies Discussed NIAGARA, TiNiVO-2, PEACE-3, CONTACT-02
|
Oct 03, 2024 |
Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12
|
Sep 26, 2024 |
WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment
|
Sep 19, 2024 |
How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes
|
Aug 29, 2024 |
How to Treat Follicular & Mantle Cell Lymphomas - Discussion with Dr. Pallawi Torka
|
Aug 22, 2024 |
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
|
Aug 15, 2024 |
How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof Warner
|
Aug 08, 2024 |
Role of Cardiology in Cancer Treatment: Cardio-Oncology
|
Aug 05, 2024 |
How to Treat Early Stage Non-Small Cell Lung Cancer
|
Aug 01, 2024 |
How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul
|
Jul 25, 2024 |
How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos
|
Jul 18, 2024 |
How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi
|
Jul 08, 2024 |
GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis
|
Jun 24, 2024 |
GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri
|
Jun 20, 2024 |
Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton
|
Jun 17, 2024 |
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
|
Jun 12, 2024 |
Multidisciplinary Treatment Approach for Rectal Cancer - Discussion with Drs. Deb Schrag & Krishan Jethwa
|
May 27, 2024 |
Zanubrutinib - FDA Approval, Efficacy & Safety Profile in CLL - Discussion with Dr. Shadman
|
May 23, 2024 |
How to treat Myelofibrosis - Discussion with Dr. Naveen Pemmaraju
|
May 20, 2024 |
Understanding Disparities in Colorectal Cancer Care
|
May 16, 2024 |
Relapsed/Refractory Multiple Myeloma Treatment Algorithm with Dr. Samer Al’Hadidi
|
May 13, 2024 |
Liver Directed Therapies - Interventional Radiology & Radiation Oncologist Perspective
|
May 09, 2024 |
Discussing Treatment Algorithm for Newly Diagnosed Multiple Myeloma with Dr. Caitlin Costello
|
May 06, 2024 |
Discussion on Evolving CLL Treatment Strategies with Dr. Nitin Jain
|
Apr 29, 2024 |
FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
|
Apr 25, 2024 |
Standard of Care Treatment for Upper GI Cancer: A Discussion with Dr. Sam Clempner
|
Apr 22, 2024 |
Standard of Care Treatment for Colon Cancer: A Discussion with Dr. Aparna Parikh
|
Apr 10, 2024 |
Unpacking the Treatment Algorithm of Hepatocellular Carcinoma with Dr. Tanios S. Bekaii-saab
|
Apr 01, 2024 |
Breakthrough in Bladder Cancer: FDA approval - Enfortumab Vedotin + Pelbrolizumab with Dr. Tom Powles
|
Mar 27, 2024 |
Bladder Cancer Treatment Algorithm Discussion with Drs. Karine Tawagi and Sia Daneshmand
|
Mar 22, 2024 |
Exploring the Latest in Renal Cell Cancer Therapies with Dr. Monty Pal using an Algorithm
|
Mar 11, 2024 |
How to treat Prostate Cancer in 2024 with Dr. Rana McKay
|
Feb 26, 2024 |
Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study
|
Feb 22, 2024 |
How to Treat HR+ Breast Cancer with Dr. Virginia Kaklamani | Onc Brothers
|
Feb 15, 2024 |
GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564
|
Feb 08, 2024 |
How to treat HER2+ Breast Cancer in 2024 with Dr. Harold Burstein
|
Feb 05, 2024 |
GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMate 8HW, EMERALD-1, NETTER-2
|
Feb 01, 2024 |